908 Devices (NASDAQ:MASS) Director Sells $19,844.00 in Stock

908 Devices Inc. (NASDAQ:MASS) Director Christopher Brown sold 2,200 shares of the business’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $9.02, for a total transaction of $19,844.00. Following the transaction, the director owned 843,359 shares of the company’s stock, valued at $7,607,098.18. This trade represents a 0.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Performance

Shares of MASS stock opened at $8.13 on Friday. 908 Devices Inc. has a 52-week low of $5.03 and a 52-week high of $9.34. The company has a market capitalization of $307.40 million, a PE ratio of -8.13 and a beta of 0.63. The business’s fifty day moving average is $8.10 and its 200 day moving average is $6.95.

Institutional Investors Weigh In On 908 Devices

Institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC purchased a new position in shares of 908 Devices in the first quarter valued at about $365,000. Geode Capital Management LLC boosted its holdings in shares of 908 Devices by 11.7% during the second quarter. Geode Capital Management LLC now owns 658,603 shares of the company’s stock worth $4,697,000 after purchasing an additional 68,764 shares during the period. Rhumbline Advisers boosted its holdings in shares of 908 Devices by 5.5% during the second quarter. Rhumbline Advisers now owns 36,416 shares of the company’s stock worth $260,000 after purchasing an additional 1,894 shares during the period. American Century Companies Inc. grew its stake in shares of 908 Devices by 22.9% in the second quarter. American Century Companies Inc. now owns 56,296 shares of the company’s stock worth $401,000 after purchasing an additional 10,482 shares during the last quarter. Finally, Walleye Capital LLC bought a new stake in shares of 908 Devices in the second quarter worth about $82,000. Hedge funds and other institutional investors own 88.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Wall Street Zen upgraded 908 Devices from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Weiss Ratings cut shares of 908 Devices from a “hold (c-)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, 908 Devices has an average rating of “Hold” and an average price target of $12.00.

About 908 Devices

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.